A rapid release tablet involves as an active ingredient tolfenamic acid or its pharmaceutically acceptable salts having a mean particle size of <10 μm, alginic acid or its pharmaceutically acceptable salts in {HEAD ~ an amount} of {TAIL ~ 1.5 6.0%} by weight, and a superdisintegrant in an amount of at least 6% by weight 
A rapid release tablet involves as an active ingredient tolfenamic acid or its pharmaceutically acceptable salts having a mean particle size of < 10 μm , alginic acid or its pharmaceutically acceptable salts in { HEAD ~ an amount } of { TAIL ~ 1.5 6.0 % } by weight , and a superdisintegrant in an amount of at least 6 % by weight
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH